Search | Page 12 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials

    ... study for patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) with poor performance, organ dysfunction or comorbidities. ...

    Research Article last updated 11/28/2016 - 11:15am.

  2. Short- and long-term benefits of lenalidomide treatment in patients with lower-risk del(5q) myelodysplastic syndromes

    ... The treatment of patients with myelodysplastic syndromes (MDS) begins with assessment of karyotype and risk. ...

    Research Article last updated 12/08/2015 - 1:06pm.

  3. Toward resolving the unsettled role of iron chelation therapy in myelodysplastic syndromes

    ... Transfusion dependent low risk myelodysplastic syndromes (MDS) patients, eventually develop iron overload . Iron ...

    Research Article last updated 04/16/2014 - 12:34pm.

  4. Prognostic factors and risk models in myelodysplastic syndromes

    ... The myelodysplastic syndromes (MDS) encompass a hematologically diverse group of neoplastic ...

    Research Article last updated 01/07/2014 - 9:23am.

  5. Myelodysplastic syndromes, version 2.2015

    ... The NCCN Guidelines for Myelodysplastic Syndromes (MDS) comprise a heterogeneous group of myeloid disorders with a ...

    Research Article last updated 04/08/2015 - 2:15pm.

  6. Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes

    ... has allowed for the detection of somatic mutations in myelodysplastic syndromes (MDS), the clinical relevance of variant allele frequency (VAF) ...

    Research Article last updated 12/08/2015 - 1:04pm.

  7. Standardizing the Initial Evaluation for Myelodysplastic Syndromes.

    ... The myelodysplastic syndromes (MDS) pose a unique diagnostic challenge for clinicians and ...

    Research Article last updated 11/05/2013 - 12:31pm.

  8. Myelodysplastic syndromes: toward a risk-adapted treatment approach.

    ... and scoring systems have been developed in myelodysplastic syndromes (MDS to predict the risk of progression to acute myeloid leukemia ...

    Research Article last updated 10/22/2013 - 3:02pm.

  9. A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes

    ... the potential utility of Chidamide for the treatment of Myelodysplastic syndromes . Bone Marrow ...

    Research Article last updated 11/02/2016 - 9:39am.

  10. The multifaceted nature of myelodysplastic syndromes: clinical, molecular, and biological prognostic features

    ... The myelodysplastic syndromes (MDS) consist of a heterogeneous spectrum of myeloid clonal ...

    Research Article last updated 08/06/2013 - 12:15pm.